Luis Fernando Tejado Gallegos

Statistics

Publications

Citations

H-Index

Active since

2022

Affiliations

AstraZeneca (Singapore)(Current)

AstraZeneca (Switzerland)

Luis Fernando Tejado Gallegos is an author at AstraZeneca (Singapore) specializing in lung cancer epidemiology, asthma severity classification, and lung adenocarcinoma.

Publications per year

2022–2024

Publications

Prevalence of EGFR Mutations in Patients With Resected Stages I to III NSCLC: Results From the EARLY-EGFR Study

Ross A. Soo, Thanyanan Reungwetwattana, Herman Andrés Perroud et al. · Journal of Thoracic Oncology · 2024 · 46 citations · Full text

Medicine, Molecular Medicine, Oncology +16

Over-prescription of short-acting β <sub>2</sub> -agonists is associated with poor asthma outcomes: results from the Latin American cohort of the SABINA III study

Felicia Montero-Arias, Jose Carlos Herrera Garcia, Manuel Pacheco et al. · Journal of Asthma · 2022 · 28 citations

Pharmacy, Internal Medicine, Pharmacotherapy +16

1–2 of 2